Myles Edward H
SEC-identified person · CIK 1358219 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Scholar Rock Holding Corp SRRK | Director · Chief Financial Officer | filed 2018–2025 |
| Amag Pharmaceuticals, INC. AVM | Chief Financial Officer | filed 2016–2020 |
| Ocata Therapeutics, Inc. OTCBB:ACTC | COO and CFO | filed 2013–2016 |
| Pressure Biosciences INC pbio | Vice President of Finance/CFO | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.